Early mechanical ventilation in patients with Guillain-Barré syndrome at high risk of respiratory failure: a randomized trial.

Acute respiratory failure Aspiration Guillain-Barré syndrome Intubation Mechanical ventilation

Journal

Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873

Informations de publication

Date de publication:
30 Sep 2020
Historique:
received: 29 11 2019
accepted: 18 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

About 30% of patients with Guillain-Barré syndrome become ventilator dependent, of whom roughly 75% develop pneumonia. This trial aimed at assessing the impact of early mechanical ventilation (EMV) on pneumonia occurrence in GBS patients. We hypothesize that EMV will reduce the incidence of pneumonia. This was a single centre, open-label, randomized controlled trial performed on two parallel groups. 50 intensive care unit adults admitted for Guillain-Barré syndrome and at risk for acute respiratory failure. Patients were randomized to early mechanical ventilation via face-mask or endotracheal intubation owing to the presence or absence of impaired swallowing (experimental arm), or to conventional care (control arm). The primary outcome was the incidence of pneumonia up to intensive care unit discharge (or 90 days, pending of which occurred first). Twenty-five patients were randomized in each group. There was no significant difference between groups for the incidence of pneumonia (10/25 (40%) vs 9/25 (36%), P = 1). There was no significant difference between groups for the time to onset of pneumonia (P = 0.50, Gray test). During follow-up, there were 16/25 (64%) mechanically ventilated patients in the control group, and 25/25 (100%) in the experimental arm (P < 000·1). The time on ventilator was non-significantly shorter in the experimental arm (14 [7; 29] versus 21.5 [17.3; 35.5], P = 0.10). There were no significant differences between groups for length of hospital stay, neurological scores, the proportion of patients who needed tracheostomy, in-hospital death, or any serious adverse events. In the present study including adults with Guillain-Barré syndrome at high risk of respiratory failure, we did not observe a prevention of pneumonia with early mechanical ventilation. ClinicalTrials.gov under the number NCT00167622. Registered 9 September 2005, https://clinicaltrials.gov/ct2/show/NCT00167622?cond=Guillain-Barre+Syndrome&cntry=FR&draw=2&rank=1.

Identifiants

pubmed: 32997260
doi: 10.1186/s13613-020-00742-z
pii: 10.1186/s13613-020-00742-z
pmc: PMC7525233
doi:

Banques de données

ClinicalTrials.gov
['NCT00167622']

Types de publication

Journal Article

Langues

eng

Pagination

128

Références

Presse Med. 1996 Oct 19;25(31):1448-52
pubmed: 8958874
Ann Neurol. 1997 Mar;41(3):298-306
pubmed: 9066350
Lancet. 1994 Jun 25;343(8913):1600-4
pubmed: 7911921
Brain Behav. 2016 Dec 20;7(2):e00611
pubmed: 28239521
N Engl J Med. 1992 Apr 23;326(17):1123-9
pubmed: 1552913
Respir Physiol Neurobiol. 2005 Apr 15;146(2-3):291-300
pubmed: 15766917
Neuroepidemiology. 2011;36(2):123-33
pubmed: 21422765
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000022
pubmed: 19821262
Crit Care Med. 2003 Jan;31(1):278-83
pubmed: 12545029
Lancet. 2009 Jul 18;374(9685):250-9
pubmed: 19616722
Neurology. 2003 Jan 14;60(1):17-21
pubmed: 12530364
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
J Peripher Nerv Syst. 2005 Jun;10(2):158-73
pubmed: 15958127
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
pubmed: 15699079
Lancet. 1997 Jan 25;349(9047):225-30
pubmed: 9014908
Semin Neurol. 2001 Dec;21(4):399-405
pubmed: 11774055
Continuum (Minneap Minn). 2015 Oct;21(5 Neurocritical Care):1324-45
pubmed: 26426233
Neurologist. 2005 Nov;11(6):338-47
pubmed: 16286877
J Infect Dis. 1997 Dec;176 Suppl 2:S92-8
pubmed: 9396689
Ann Surg. 1985 Dec;202(6):685-93
pubmed: 4073980
Curr Opin Crit Care. 2016 Apr;22(2):94-9
pubmed: 26872323
Lancet Infect Dis. 2013 Apr;13(4):328-41
pubmed: 23352693
Can J Neurol Sci. 2006 Feb;33(1):105-6
pubmed: 16583732
Cochrane Database Syst Rev. 2014 Sep 19;(9):CD002063
pubmed: 25238327
Neurocrit Care. 2004;1(4):415-22
pubmed: 16174943
Transfus Sci. 1999 Feb;20(1):53-61
pubmed: 10621561
Intensive Care Med. 2006 Dec;32(12):1962-9
pubmed: 17019557
Respir Care. 2006 Sep;51(9):1016-21; discussion 1021-3
pubmed: 16934165
Lancet. 1983 Sep 24;2(8352):741
pubmed: 6136869

Auteurs

Marie-Anne Melone (MA)

Respiratory, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France. m_a.melone@icloud.com.

Nicholas Heming (N)

Medical Intensive Care Unit, Raymond Poincaré Teaching Hospital, 104 boulevard Raymond Poincaré, 92380, Garches, France.

Paris Meng (P)

Medical Intensive Care Unit, Raymond Poincaré Teaching Hospital, 104 boulevard Raymond Poincaré, 92380, Garches, France.

Dominique Mompoint (D)

Radiology Department, Raymond Poincaré Teaching Hospital, Garches, France.

Jerôme Aboab (J)

Medical Intensive Care Unit, Raymond Poincaré Teaching Hospital, 104 boulevard Raymond Poincaré, 92380, Garches, France.

Bernard Clair (B)

Medical Intensive Care Unit, Raymond Poincaré Teaching Hospital, 104 boulevard Raymond Poincaré, 92380, Garches, France.

Jerôme Salomon (J)

Infectious Diseases Department, Raymond Poincaré Teaching Hospital, Garches, France.

Tarek Sharshar (T)

Medical Intensive Care Unit, Raymond Poincaré Teaching Hospital, 104 boulevard Raymond Poincaré, 92380, Garches, France.

David Orlikowski (D)

Medical Intensive Care Unit, Raymond Poincaré Teaching Hospital, 104 boulevard Raymond Poincaré, 92380, Garches, France.

Sylvie Chevret (S)

Biostatistic Team, Saint Louis Hospital, Paris, France.

Djillali Annane (D)

Medical Intensive Care Unit, Raymond Poincaré Teaching Hospital, 104 boulevard Raymond Poincaré, 92380, Garches, France.

Classifications MeSH